EUVIMEDEUVIMED entdecken
Open Access

The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men

Peter Kf Chiu, Thomas Yt Lam, Chi-Fai Ng, Jeremy Yc Teoh, Carmen Cm Cho, Hiu-Yee Hung, Cindy Hong, Monique J Roobol, Winnie Cw Chu, Samuel Ys Wong, Joseph Jy Sung

Asian Journal of Andrology · 2023

DOI: 10.4103/aja20239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Andrology, 2023. Verfasst von Peter Kf Chiu und 10 weiteren Autor:innen. Beteiligte Einrichtung: SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using prostate-specific antigen (PSA) for prostate cancer (PCa) screening led to overinvestigation and overdiagnosis of indolent PCa. We aimed to investigate the value of prostate health index (PHI) and magnetic resonance imaging (MRI) prostate in an Asian PCa screening program. Men aged 50–75 years were prospectively recruited from a community-based PSA screening program. Men with PSA 4.0–10.0 ng ml −1 had PHI result analyzed. MRI prostate was offered to men with PSA 4.0–50.0 ng ml −1 . A systematic prostate biopsy was offered to men with PSA 4.0–9.9 ng ml −1 and PHI ≥35, or PSA 10.0–50.0 ng ml −1 . Additional targeted prostate biopsy was offered if they had PI-RADS score ≥3. Clinically significant PCa (csPCa) was defined as the International Society of Urological Pathology (ISUP) grade group (GG) ≥2 or ISUP GG 1 with involvement of ≥30% of total systematic cores. In total, 12.8% (196/1536) men had PSA ≥4.0 ng ml −1 . Among 194 men with PSA 4.0–50.0 ng ml −1 , 187 (96.4%) received MRI prostate. Among them, 28.3% (53/187) had PI-RADS ≥3 lesions. Moreover, 7.0% (107/1536) men were indicated for biopsy and 94.4% (101/107) men received biopsy. Among the men received biopsy, PCa, ISUP GG ≥2 PCa, and csPCa was diagnosed in 42 (41.6%), 24 (23.8%), and 34 (33.7%) men, respectively. Compared with PSA/PHI pathway in men with PSA 4.0–50.0 ng ml −1 , additional MRI increased diagnoses of PCa, ISUP GG ≥2 PCa, and csPCa by 21.2% (from 33 to 40), 22.2% (from 18 to 22), and 18.5% (from 27 to 32), respectively. The benefit of additional MRI was only observed in PSA 4.0–10.0 ng ml −1 , and the number of MRI needed to diagnose one additional ISUP GG ≥2 PCa was 20 in PHI ≥35 and 94 in PHI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsHumansMaleEarly Detection of CancerEast Asian PeopleImage-Guided BiopsyMagnetic Resonance ImagingProstateProstate-Specific AntigenRetrospective StudiesMiddle AgedAged

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Erasmus MC Cancer Institute, Erasmus Medical University, Rotterdam 3015, The Netherlands.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.

Zitieren

APA

Chiu, P. K., Lam, T. Y., Ng, C. F., Teoh, J. Y., Cho, C. C., Hung, H. Y., Hong, C., Roobol, M. J., Chu, W. C., Wong, S. Y., & Sung, J. J. (2023). The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men. Asian Journal of Andrology. https://doi.org/10.4103/aja20239

Vancouver

Chiu PK, Lam TY, Ng CF, Teoh JY, Cho CC, Hung HY, et al. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men. Asian Journal of Andrology. 2023. doi:10.4103/aja20239

BibTeX
@article{Chiu2023,
  author = {Chiu, Peter Kf and Lam, Thomas Yt and Ng, Chi-Fai and Teoh, Jeremy Yc and Cho, Carmen Cm and Hung, Hiu-Yee and Hong, Cindy and Roobol, Monique J and Chu, Winnie Cw and Wong, Samuel Ys and Sung, Joseph Jy},
  title = {The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men},
  journal = {Asian Journal of Andrology},
  year = {2023},
  doi = {10.4103/aja20239}
}
Kostenlos starten →